Medical experts have warned Britons not to turn to fake weight loss jabs after fears the Mounjaro price hike could make it ...

Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK ...

US pharma major Eli Lilly is raising the list price for its obesity drug Mounjaro (tirzepatide) in the UK by as much as 170%, as the pharma industry comes under pressure from US President Donald Trump ...

Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be unaffected.

September S&P 500 E-Mini futures (ESU25) are trending up +0.17% this morning, bolstered by continued hopes for a Federal ...

AbbVie unveiled a $195 million investment to expand active pharmaceutical ingredient manufacturing in the U.S. Bloomberg reported that BlinkRx, a company that has Donald Trump Jr. on its board, just ...

This episode of Pharma Pulse discusses a new executive order to build a domestic API stockpile, Eli Lilly’s 170% price ...

Lyft's co-founders Logan Green and John Zimmer are stepping down from their roles as chair and vice chair of the board of directors. Soros, Appaloosa boost their Nvidia stake. They also bought this ...

Huge dividends from Denmark’s weight loss drug industry are result of high-tax and high-investment economy, says Nobel Prize winner Morten Meldal.

Eli Lilly and Co (NYSE: LLY) has entered into a $1.3 billion deal with Superluminal Medicines to develop small-molecule drugs ...

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...